Contra-indicated in patients with known or suspected mechanical gastrointestinal obstruction.
- TRADE NAME: Linzess (Forest)
- INDICATIONS: Irritable bowel syndrome with constipation and chronic idiopathic constipation
- CLASS: Amino acid, Guanylate cyclase-C agonist
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
PEDIATRIC RISK
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 01/12/2024
